Last updated 18 June 2026. Educational content, not medical advice. Retatrutide (LY3437943) is an investigational compound in Phase 3 clinical trials and is not FDA-approved. Consult a licensed clinician before using any research peptide.

Short answer: Reconstituted retatrutide mixed with bacteriostatic water (0.9% benzyl alcohol) lasts 28 to 30 days when stored at 2 to 8°C in a standard refrigerator. Beyond that window, the peptide degrades through hydrolysis and oxidation regardless of whether the vial looks clear, and potency can no longer be assumed. A lyophilized (freeze-dried) vial kept sealed at minus 20°C is stable for up to 24 months before reconstitution.

Why does the 28-day number matter so much?

Once you puncture the stopper and add liquid, the clock starts and does not stop. Retatrutide is a 39-amino-acid triple agonist peptide, meaning it acts simultaneously on GLP-1, GIP, and glucagon receptors, and that structural complexity is precisely why it degrades faster than a simple single-receptor compound like a collagen fragment.

The degradation is not always visible. A vial reconstituted five weeks ago and stored correctly at 4°C can look perfectly clear, smell like nothing, and still have lost 20 to 30% of its active peptide content through oxidation and deamidation of its glutamine and asparagine residues. You cannot tell by looking.

The 28-day rule is not a conservative guess from a cautious label writer. It is derived from the same stability science used to set expiration windows for pharmacy-compounded GLP-1 injectables, including compounded semaglutide and tirzepatide, where regulators require documented potency testing at the outer edge of the claimed shelf life. Applied to retatrutide, the benchmarks from GLP3 Planner’s storage stability resource and SeekPeptides’ shelf life guide consistently land at 28 to 30 days refrigerated with bacteriostatic water.

What happens chemically after reconstitution?

Understanding the mechanism helps you understand why temperature and solvent choice dominate every storage recommendation.

When lyophilized retatrutide is reconstituted, water becomes available and three degradation pathways activate almost immediately. The first is hydrolysis, where water molecules cleave peptide bonds at the most vulnerable spots in the amino acid chain. The second is deamidation, where asparagine (Asn) and glutamine (Gln) residues lose their amide groups and convert to aspartate and glutamate, altering the molecular structure in ways that reduce receptor-binding efficiency. The third is oxidation, where methionine (Met) and cysteine (Cys) residues react with dissolved oxygen in the liquid.

Cold temperature slows all three pathways significantly. Every 10°C increase in storage temperature roughly doubles the rate of chemical degradation in most peptide solutions, which is why the difference between 4°C and 25°C is not cosmetic.

Bacteriostatic water adds a fourth protection layer: the 0.9% benzyl alcohol acts as an antimicrobial preservative, preventing bacterial growth across the multi-use life of the vial. Sterile water provides no such protection. If you reconstitute with sterile water instead of bacteriostatic water, the practical shelf life collapses to 24 to 48 hours, because bacterial contamination can occur from repeated needle insertions even when technique is careful.

The full shelf-life breakdown across storage conditions

Storage condition Vial state Shelf life Key limitation
Minus 20°C (freezer) Lyophilized, sealed Up to 24 months Do not freeze after reconstitution
2 to 8°C (fridge) Lyophilized, sealed 12 to 18 months Keep away from door / temp fluctuation
2 to 8°C (fridge) Reconstituted, BAC water 28 to 30 days Firm outer limit; discard after
2 to 8°C (fridge) Reconstituted, sterile water 24 to 48 hours No antimicrobial protection
Room temperature (20 to 25°C) Reconstituted Hours to 1 day Not a safe storage option
Freezer Reconstituted Not recommended Freeze-thaw cycles damage peptide bonds

The numbers in this table align with consensus guidance from Palmetto Peptides’ storage guide, Stage Research’s stability page, and Loti Labs’ reconstituted peptide shelf-life resource.

One number from that table is worth pausing on: the 24-month ceiling for a lyophilized vial stored at minus 20°C. That is not a rule of thumb. It reflects the fact that even freeze-dried peptides experience slow solid-state degradation, and that the 2-year mark is where most independent stability assessments show potency dropping below 90% even under ideal conditions. For a compound as structure-dependent as retatrutide, whose mechanism of action relies on precise receptor contact geometry, a 90% potency vial is meaningfully different from a 99% potency vial, even if both “look fine.”

Editor pick · Whole-body optimization
Superpower

Full-body lab membership: 100+ biomarkers, doctor-reviewed, tracked over time.

How to store reconstituted retatrutide correctly

The storage protocol is not complicated, but the margin for error is smaller than most people assume. Here are the specifics that actually matter.

Temperature placement inside the refrigerator: The fridge door is the single worst place to store any peptide vial. Door temperature swings by 2 to 4°C each time you open it. Place the reconstituted vial in the back of a middle shelf, where the temperature is most stable and closest to the rated 4°C. A fridge thermometer costs roughly $10 and pays for itself the first time it prevents you from discarding a degraded vial you thought was fine.

Light protection: Retatrutide degrades faster under UV and visible-light exposure. Wrap the vial in aluminum foil, use an opaque storage case, or keep it in an amber glass vial if you have one. A dark drawer in the fridge is better than the main shelf if your fridge has an interior light that stays on.

Labeling: Write the reconstitution date directly on the vial with a permanent marker. The single most common reason a person uses a degraded peptide is that they forgot exactly when they mixed it. “About three weeks ago” is not good enough for something that expires at exactly four weeks.

Do not shake: Reconstituted peptides should be gently swirled, never shaken. Mechanical agitation creates air bubbles and can induce aggregation, which means the peptide clumps into inactive particles. This is different from the foam on a protein shake; in a peptide solution, those aggregated particles are biologically inert and cannot bind receptors.

Do not re-freeze after reconstitution: Freezing a reconstituted peptide solution forces ice crystals to form, and those crystals puncture and shear the amino acid chain physically, independent of any chemical mechanism. A freeze-thaw cycle can destroy 15 to 30% of the active peptide in a single occurrence. The lyophilized powder tolerates freezing because the water was removed by design under controlled conditions. The reconstituted solution does not.

Signs that a reconstituted vial has degraded

Personally, I think this is the most under-discussed part of peptide storage, because most people check for obvious contamination and stop there. The visible signs are real but incomplete.

Visible degradation markers:
– Cloudiness or haziness that was not present after initial reconstitution. Clear-to-cloudy is the most reliable visual indicator of aggregation or bacterial contamination.
– Particulates, specks, or fibers floating in the solution.
– A color shift. A pure retatrutide solution in bacteriostatic water should be colorless to slightly off-white. Any yellowing or browning suggests significant oxidation.
– Separation layers or an oily appearance at the surface.

Less obvious markers most researchers miss:
– A vial that takes longer than usual to fully dissolve fragments when gently swirled may have partial aggregation occurring at the stopper or in solution. The fully dissolved state should look the same every time.
– A vial that has experienced even one brief temperature excursion above 25°C, such as being left out while you prepared other supplies, should be regarded as outside its validated window, even if it looks unchanged.

Do not believe the advice that says “if it smells fine, it is fine.” Retatrutide peptide solutions should have essentially no odor. The presence of any unfamiliar smell is a definitive red flag, but the absence of smell confirms nothing about potency.

Lyophilized vs. reconstituted: the choice that determines your shelf life

The single highest-impact storage decision is made at the moment of reconstitution, not after. Because the lyophilized form is stable for up to 24 months at minus 20°C and the reconstituted form expires in 28 days, the question of when to reconstitute is a legitimate strategy decision for anyone managing a longer research timeline.

The standard guidance from compounding pharmacy literature, applied here by analogy: reconstitute only what you will use within 28 days. If you have a 10 mg vial and your protocol calls for 2 mg weekly, reconstitute the full vial (which is the correct approach for accurate concentration math) and plan the four-use cycle over no more than four weeks. If your research timeline is paused for any reason, a sealed lyophilized vial in the freezer keeps the option open without the ticking clock of a reconstituted vial in the fridge.

The corollary that surprises most first-time users: buying multiple vials in bulk and reconstituting them all at once is one of the fastest ways to waste potency. One vial at a time, reconstituted to align with a 4-week window, maximizes the potency of what you use.

What about traveling with a reconstituted vial?

Travel is where cold-chain discipline breaks down and good intentions meet bad outcomes. The practical rules:

If possible, travel with the lyophilized powder and reconstitute at your destination. A sealed vial with a factory crimp cap has no cold-chain requirement for short trips (the lyophilized form tolerates room temperature for several weeks) and eliminates all the airport-security complexity around medical liquids.

If you must travel with a reconstituted vial, TSA explicitly allows reconstituted peptide solutions in carry-on bags under the medical liquids exemption, separate from the standard 3.4 oz rule, but you must declare them at the checkpoint (TSA medical liquids guidance, vialcase.com). Use a sealed medical cooler with gel ice packs; never place vials in direct contact with a frozen pack, as surface temperature below 0°C can damage the solution even if the bulk temperature stays above freezing. Any trip that disrupts refrigeration for more than four hours is a risk to potency, and any trip that takes the vial above 25°C for more than 30 minutes should reset your confidence in the remaining shelf life.

Retatrutide’s regulatory status in 2026: why this matters for storage questions

Retatrutide is not an FDA-approved medication. It is an investigational drug developed by Eli Lilly under the compound identifier LY3437943. In May 2026, Eli Lilly announced positive topline results from TRIUMPH-1, the first Phase 3 obesity trial, with the 12 mg dose delivering an average 28.3% body weight loss over 80 weeks in 2,339 participants, representing the largest weight loss ever documented in a Phase 3 obesity trial, ahead of tirzepatide (22.5% in SURMOUNT-1) by nearly 6 percentage points (Lilly investor release).

An NDA filing is on track for Q4 2026, with FDA approval expected no earlier than late 2027 and a market launch projected for Q1 to Q2 2028.

This regulatory gap is the reason this storage guide exists. Because Eli Lilly’s approved retatrutide auto-injector pen does not yet exist on the market, anyone accessing retatrutide in 2026 is working with either a compounded prescription through a licensed clinic or a research-grade lyophilized vial that requires reconstitution. The compounded route carries a pharmacist and a clinician; the research-grade route puts all storage and handling responsibility on the user.

Retatrutide does not appear on the FDA’s 503A bulk drug substances list as a permitted compound for compounding, which makes its legal status for compounding genuinely murky, and considerably murkier than BPC-157 or sermorelin, which have clearer (if still evolving) regulatory frameworks. If you want access to retatrutide through a clinician, the realistic current path is a licensed clinical trial (where it is free and fully monitored) or a telehealth provider with documented medical oversight and pharmacy sourcing they can name explicitly.

Editor pick · Guided GLP-1 access
Ro

Telehealth GLP-1 program with provider visits and pharmacy coordination.

The most common storage mistakes, and why they happen

Personally, I see three mistakes show up repeatedly in research community forums, and all three are preventable.

Mistake 1: Trusting the door shelf. The rationale is always “it is easier to grab.” The reality is that door-shelf temperature in a typical household refrigerator swings between 5 and 10°C over the course of a day. For a 28-day stability window, cumulative thermal stress matters; every excursion above 8°C shortens the effective shelf life. Store it in the back.

Mistake 2: The “it looks clear” assumption. Potency degradation through deamidation is invisible. The vial looks identical on day 28 to how it looked on day 3. Visual inspection rules out microbial contamination, but it does not measure potency. The 28-day window is the potency limit, not a contamination indicator.

Mistake 3: Reconstituting with sterile water to save money on bacteriostatic water. Bacteriostatic water costs approximately $8 to $12 per 30 mL vial and is the difference between a 28-day shelf life and a 24-hour shelf life. This is one of the most lopsided cost-benefit calculations in peptide handling.

Frequently asked questions

How long does reconstituted retatrutide last in the fridge?
28 to 30 days when reconstituted with bacteriostatic water and stored at 2 to 8°C. After that window, potency cannot be reliably assumed due to hydrolysis and oxidation of the peptide chain. Discard and reconstitute a new vial.

Can you freeze reconstituted retatrutide to extend shelf life?
No. Freezing a reconstituted peptide solution causes ice crystal formation that physically damages the amino acid chain. The only form of retatrutide that can be safely frozen is the lyophilized (freeze-dried) powder before any liquid is added. Freeze-thaw damage is irreversible and can destroy 15 to 30% of active peptide in a single cycle.

What happens if I use retatrutide after 30 days?
The compound has likely degraded through hydrolysis, deamidation, or oxidation to a degree that reduces its receptor-binding activity. Because degradation is invisible, there is no reliable way to assess what potency remains. The 28-day window is the outer boundary set by the chemistry, not an arbitrary buffer.

How long does lyophilized (freeze-dried) retatrutide powder last before reconstitution?
A sealed lyophilized vial stored at minus 20°C is stable for up to 24 months. At standard refrigerator temperature (2 to 8°C), an unopened vial is stable for 12 to 18 months. Once the vial is punctured, even if you have not added water, the integrity of the crimp seal is compromised and the clock on the dry powder shortens.

Does bacteriostatic water vs. sterile water matter for shelf life?
Yes, substantially. Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial growth across the multi-draw life of the vial and extends the viable shelf life of the reconstituted solution to 28 to 30 days. Sterile water has no preservative, limiting safe use to 24 to 48 hours.

How do I know if my reconstituted retatrutide has gone bad?
Visible signs include cloudiness, particulates, color change to yellow or brown, and separation layers. However, potency degradation through deamidation and oxidation produces no visible change. A vial past the 28-day window should be discarded even if it appears normal.

Can I travel by airplane with reconstituted retatrutide?
Yes, under TSA’s medical liquids exemption. Declare the vials at the checkpoint and keep them in an insulated medical cooler with gel packs. Do not place vials in direct contact with frozen packs. Whenever the trip permits, traveling with lyophilized powder and reconstituting at the destination eliminates cold-chain risk entirely.

Author: Vital Signs Today Editorial Team, [credential]”]. Educational content, not medical advice. Sources linked inline.

Primary sources:

Related reading